Omega Therapeutics, Inc. (OMGA) DCF Valuation

Omega Therapeutics, Inc. (OMGA) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Omega Therapeutics, Inc. (OMGA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insights into your Omega Therapeutics, Inc. (OMGA) valuation analysis with our powerful DCF Calculator! Equipped with real data for (OMGA), this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of Omega Therapeutics, Inc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .1 2.1 3.1 4.2 5.8 8.0 11.0 15.1
Revenue Growth, % 0 0 0 1339.58 49.25 37.31 37.31 37.31 37.31 37.31
EBITDA -16.5 -27.5 -64.6 -97.6 -93.5 -.8 -1.2 -1.6 -2.2 -3.0
EBITDA, % 100 100 -44892.36 -4706.99 -3021.65 -20 -20 -20 -20 -20
Depreciation .8 1.1 1.4 5.2 6.8 4.2 5.8 8.0 11.0 15.1
Depreciation, % 100 100 963.19 250.36 218.84 100 100 100 100 100
EBIT -17.3 -28.6 -66.0 -102.8 -100.3 -.8 -1.2 -1.6 -2.2 -3.0
EBIT, % 100 100 -45855.55 -4957.36 -3240.5 -20 -20 -20 -20 -20
Total Cash 2.3 23.0 225.3 70.6 73.4 4.2 5.8 8.0 11.0 15.1
Total Cash, percent .0 .0 .2 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .2 .5 1.8 7.0
Account Receivables, % 100 100 361.81 86.73 225.79
Inventories .0 .0 -.3 41.2 .3 1.8 2.4 3.4 4.6 6.3
Inventories, % 100 100 -183.33 1985.09 9.79 41.96 41.96 41.96 41.96 41.96
Accounts Payable .9 1.1 2.1 3.1 1.6 3.8 5.3 7.2 10.0 13.7
Accounts Payable, % 100 100 1464.58 149.88 52.36 90.47 90.47 90.47 90.47 90.47
Capital Expenditure -.9 -1.8 -1.5 -1.4 -2.9 -2.2 -3.0 -4.2 -5.7 -7.8
Capital Expenditure, % 100 100 -1018.75 -66.57 -92.73 -51.86 -51.86 -51.86 -51.86 -51.86
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -17.9 -29.4 -66.9 -102.7 -100.3 -.8 -1.2 -1.6 -2.2 -3.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -17.1 -30.1 -66.0 -140.6 -62.2 4.8 .9 1.2 1.6 2.2
WACC, % 6.7 6.7 6.7 6.7 6.7 6.7 6.7 6.7 6.7 6.7
PV UFCF
SUM PV UFCF 9.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 2
Terminal Value 49
Present Terminal Value 35
Enterprise Value 44
Net Debt 60
Equity Value -16
Diluted Shares Outstanding, MM 54
Equity Value Per Share -0.29

What You Will Get

  • Real OMGA Financials: Access historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Omega Therapeutics’ future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive OMGA Data: Pre-filled with Omega Therapeutics’ historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, profit margins, discount rates, tax assumptions, and capital investments.
  • Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • User-Friendly Interface: Intuitive, organized, and tailored for both professionals and newcomers.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based OMGA DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Omega Therapeutics' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the results to inform your investment or financial strategy.

Why Choose Omega Therapeutics, Inc. (OMGA)?

  • Innovative Solutions: Cutting-edge therapies designed to address unmet medical needs.
  • Expert Team: A dedicated team of scientists and professionals driving research forward.
  • Robust Pipeline: A diverse array of potential treatments in various stages of development.
  • Commitment to Quality: Stringent standards ensure the highest levels of safety and efficacy.
  • Collaborative Approach: Partnerships with leading institutions to enhance research and development.

Who Should Use This Product?

  • Biotech Students: Understand drug development processes and apply them using real-world data.
  • Researchers: Integrate cutting-edge models into academic studies or clinical research.
  • Investors: Evaluate your own hypotheses and analyze valuation outcomes for Omega Therapeutics, Inc. (OMGA).
  • Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model.
  • Healthcare Entrepreneurs: Discover how large biotech firms like Omega Therapeutics are evaluated in the market.

What the Template Contains

  • Pre-Filled Data: Includes Omega Therapeutics, Inc.'s (OMGA) historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Omega Therapeutics, Inc.'s (OMGA) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.